Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 7, 2022; 28(21): 2302-2319
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2302
Published online Jun 7, 2022. doi: 10.3748/wjg.v28.i21.2302
Figure 4 Conditioned media generated using oesophageal adenocarcinoma patient tumour was screened for markers by multiplex immunosorbent assay kit.
Angiogenic markers Flt-1, basic fibroblast growth factor (bFGF), placental growth factor (PIGF) and vascular endothelial growth factor (VEGF)-A and vascular injury marker C-reactive protein (CRP) decrease significantly with 4 Gy radiation (n = 9). A: Flt-1; B: GITH; C: bFGF; D: CRP; E: PIGF; F: VEGF-A. aP < 0.05 by Wilcoxon signed rank test.
- Citation: Donlon NE, Davern M, O’Connell F, Sheppard A, Heeran A, Bhardwaj A, Butler C, Narayanasamy R, Donohoe C, Phelan JJ, Lynam-Lennon N, Dunne MR, Maher S, O’Sullivan J, Reynolds JV, Lysaght J. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma. World J Gastroenterol 2022; 28(21): 2302-2319
- URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i21.2302